Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F5BY
|
|||
Former ID |
DNC006664
|
|||
Drug Name |
N-(4-amino-6-butoxy-5-cyanopyridin-2-yl)acetamide
|
|||
Synonyms |
N-(4-amino-6-butoxy-5-cyanopyridin-2-yl)acetamide; CHEMBL378980; SCHEMBL1145050; BDBM15960; Aminopyridine-Based Inhibitor 19d
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C12H16N4O2
|
|||
Canonical SMILES |
CCCCOC1=C(C(=CC(=N1)NC(=O)C)N)C#N
|
|||
InChI |
1S/C12H16N4O2/c1-3-4-5-18-12-9(7-13)10(14)6-11(16-12)15-8(2)17/h6H,3-5H2,1-2H3,(H3,14,15,16,17)
|
|||
InChIKey |
BOEQDOKWKLSDFP-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity. J Med Chem. 2006 Jun 15;49(12):3563-80. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.